» Articles » PMID: 38002848

An Integrated Approach Using HLAMatchmaker and Pirche II for Epitopic Matching in Pediatric Kidney Transplant-A Romanian Single-Center Study

Abstract

(1) Background: Renal transplantation (KT) is the most efficient treatment for chronic kidney disease among pediatric patients. Antigenic matching and epitopic load should be the main criteria for choosing a renal graft in pediatric transplantation. Our study aims to compare the integration of new histocompatibility predictive algorithms with classical human leukocyte antigen (HLA) matching regarding different types of pediatric renal transplants. (2) Methods: We categorized our cohort of pediatric patients depending on their risk level, type of donor and type of transplantation, delving into discussions surrounding their mismatching values in relation to both the human leukocyte antigen Matchmaker software (versions 4.0. and 3.1.) and the most recent version of the predicted indirectly identifiable HLA epitopes (PIRCHE) II score. (3) Results: We determined that the higher the antigen mismatch, the higher the epitopic load for both algorithms. The HLAMatchmaker algorithm reveals a noticeable difference in eplet load between living and deceased donors, whereas PIRCHE II does not show the same distinction. Dialysis recipients have a higher count of eplet mismatches, which demonstrates a significant difference according to the transplantation type. Our results are similar to those of four similar studies available in the current literature. (4) Conclusions: We suggest that an integrated data approach employing PIRCHE II and HLAMatchmaker algorithms better predicts histocompatibility in KT than classical HLA matching.

Citing Articles

The Evaluation of Serum KIM-1 in a Pediatric Cohort of Renal Transplantation-A Pilot Study.

Aldea P, Turbuleasa-Jurje R, Bulata B, Delean D, Elec F, Ciumarnean L Children (Basel). 2025; 12(1).

PMID: 39857894 PMC: 11764347. DOI: 10.3390/children12010063.


HLA Diversity in Transylvanian Ethnic Groups: Consequences for Hematopoietic Cell Transplantation.

Dican L, Iancu M, Elec F, Burghelea D, Timoce R, Catana C Life (Basel). 2024; 14(10).

PMID: 39459542 PMC: 11508996. DOI: 10.3390/life14101243.

References
1.
Xiang F, Zhu J, Cao X, Shen B, Zou J, Liu Z . Lymphocyte depletion and subset alteration correlate to renal function in chronic kidney disease patients. Ren Fail. 2015; 38(1):7-14. DOI: 10.3109/0886022X.2015.1106871. View

2.
Ming Y, Peng B, Guo X, Luo W, Shao M, Cheng K . Posttransplant-Alloantibodies Against MICA Antigens Associated With Decreased Long-Term Allograft Survival of Kidney Transplant Recipients. Transplant Proc. 2022; 54(7):1801-1808. DOI: 10.1016/j.transproceed.2022.03.064. View

3.
Spitznagel T, Matter L, Kaufmann Y, Nilsson J, Moos S, Schachtner T . PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies. Front Immunol. 2022; 13:949933. PMC: 9428698. DOI: 10.3389/fimmu.2022.949933. View

4.
Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F . Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation. Am J Transplant. 2017; 17(12):3076-3086. DOI: 10.1111/ajt.14393. View

5.
Tambur A, Campbell P, Chong A, Feng S, Ford M, Gebel H . Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. Am J Transplant. 2020; 20(10):2652-2668. PMC: 7586936. DOI: 10.1111/ajt.15937. View